Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price

Glucocorticosteriods (GCS) in Allergic Inflammation, An Issue of Immunology and Allergy Clinics

9781416026778
362.83 zł
326.55 zł Save 36.28 zł Tax included
Lowest price within 30 days before promotion: 326.55 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
This issue provides a comprehensive review of the use of corticosteroids to treat allergic inflammation. Authors discuss methods of corticosteroid delivery; dose-responsiveness; clinical benefits; adherence challenges; initiation, duration and dose reduction; adverse reactions, among other topics.
Product Details
Saunders
32789
9781416026778
9781416026778

Data sheet

Publication date
2005
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
363
  • 1. Molecular Mechanisms and Cellular Effects of GCS (Barnes)
    2. Comparative Pharmacology, Bioavailability, Pharmacokinetics, and Pharmacodynamics of GCS (Derendorf)
    3. Clonical Benefits in Asthma (including discussion of formulations and devices used for ICS delivery, and critical design elements of controlled clinical trials) (Bisgaard)
    4. Clinical Benefits in Allergic Rhinitis/Sinusitis/Otitis Media (including discussion of formulation and devices used for INCS delivery, and critical design elements of controlled clinical trials) (van Cauwenberge)
    5. Effects of GCS (oral CS/ICS/INCS and combinations of these) on the Eyes and Skin in Children and Adults (Bielory and Beltrani)
    6. Effects of GCS (oral CS/ICS/INCS and combinations of these) on Bone Growth and Density in Children and Adults (Pederson)
    7. Effects of GCS (oral CS/ICS/INCS and combinations of these) on the HPA Axis in Children and Adults (Eid)
    8. Analysis of Benefit:Risk Ratio for Oral CS/ICS/INCS (and combinations of these) (Mortimer and Tattersfield)
    9. Initiation (step-up/step-down), Dose Reductions, and Duration of GCS Therapy
    10. GCS Respones: Varibility, Resistance, and Dose Relatedness for Benefits and Risk in Asthma and Allergic Rhintis (Spahn)
    11. Steroid Phobia and Adherence-Problems, Solutions, Impact on Benefit/Risk Profile (Apter and Rao)
    12. Evolution and Positoning of GCS in National/Interational Asthma and Allergic Rhinitis Guidelines (vs. other therapies) (Pauwels, Bousquet, van Cauwenberge, Brusselle and Joos)
Comments (0)
Viewed products

  • Frequently purchased together

    No products available